Common Equity: The sum of all common equity items.
Sarepta Therapeutics, Inc. (SRPT) had Common Equity of $1.51B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$730.80M |
|
$330.96M |
|
$108.77M |
|
$622.03M |
|
$372.37M |
|
$358.43M |
|
$-15.26M |
|
$343.17M |
|
$343.17M |
|
$330.96M |
|
$330.96M |
|
$330.96M |
|
$330.96M |
|
$358.43M |
|
$368.50M |
|
104.99M |
|
121.92M |
|
$3.15 |
|
$2.88 |
|
| Balance Sheet Financials | |
$2.31B |
|
$336.24M |
|
$869.06M |
|
$3.18B |
|
$499.16M |
|
$838.16M |
|
$1.17B |
|
$1.67B |
|
|
Common Equity |
$1.51B |
$1.51B |
|
$1.51B |
|
105.57M |
|
| Cash Flow Statement Financials | |
$-202.68M |
|
$-134.39M |
|
$0.24M |
|
$814.41M |
|
$477.57M |
|
$-336.83M |
|
$29.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.63 |
|
-- |
|
-- |
|
0.36 |
|
0.56 |
|
85.12% |
|
49.05% |
|
49.05% |
|
-- |
|
46.96% |
|
45.29% |
|
$-204.76M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.11 |
|
1.85 |
|
48.62 |
|
21.99% |
|
21.99% |
|
10.41% |
|
14.12% |
|
$14.26 |
|
$-1.68 |
|
$-1.66 |
|